Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tree

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 11, 2008
Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantationV A L Huurman, J H L Velthuis, R Hilbrands, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
Frontiers in Immunology|November 22, 2019
Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow CytometryJennie H M Yang, Leena Khatri, Marius Mickunas, et al.
Frontiers in Immunology|November 1, 2023
Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humansStephanie J Hanna, Terri C Thayer, Emma J S Robinson, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptorsMarcin L Pekalski, Ricardo C Ferreira, Richard M R Coulson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2016
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn BindingJulie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2017
Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn BindingJulie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 11, 2008
Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantationV A L Huurman, J H L Velthuis, R Hilbrands, et al.
European Journal of Immunology|January 13, 2022
Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetesJennie H M Yang, Kirsten A Ward-Hartstonge, Daniel J Perry, et al.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
Frontiers in Immunology|November 22, 2019
Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow CytometryJennie H M Yang, Leena Khatri, Marius Mickunas, et al.
Frontiers in Immunology|November 1, 2023
Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humansStephanie J Hanna, Terri C Thayer, Emma J S Robinson, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptorsMarcin L Pekalski, Ricardo C Ferreira, Richard M R Coulson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2016
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn BindingJulie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2017
Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn BindingJulie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Pageof 12